- Action
- On 5/8/24, correction notices were sent to Lab Managers and Risk Managers asking them to do the following:
1) Discuss the content of this letter with your laboratory management regarding the need to review previous test results associated with these affected lots.
2) Discard all products subject to the recall following your institution s process for destruction.
3) Share and post this customer letter within your facility network and forward to any customers to whom you may have distributed the product to ensure awareness.
4) Complete and return the response form via email to BDRC13@bd.com or fill out the form using this link: https://bdx.my.site.com/CC360/s/impactedproducts?rn=BDB-24-5033
If you require further assistance contact the firm's North American Reginal Complaint Center via phone 1-844-823-5433 Say "Complaints" when prompted Mon Fri 8:00am and 5:00pm CT or via email productcomplaints@bd.com Recall-related questions can be sent via email to BDRC13@bd.com
- Initiated
- 2024-05-08
- Root cause
- Material/Component Contamination
- Distribution
- US: MN, NJ, NY, MD, UT, FL, NC, MA, KY, NE, NV, CA, LA, DC, OH, MI, PA, WA, CT, AL, DE, TN, IN, OR, IL, WI, NH, TX, GA, RI, SD, ID, NM, AR.
OUS: CA, SG, NZ, AU, KR, IN, PE, GT, AR, MX, TW, CN, NI, CR, JP, BR, TH, BE, VN
- Recall number
- Z-2351-2024
- Recall status
- Open, Classified
- CDRH record ID
- 208447
- FDA classified
- 2024-07-12
- Recall event number
- 94830